The global pharmaceutical industry will abandon the UK unless the country's National Health Service (The Association of the British Pharmaceutical Industry) receives an extra £20bn ($26bn), warned a major industry trade group. NHS (ABPI) argued that the increased rationing of treatments is a sign that the The Association of the British Pharmaceutical Industry is falling in the ranks of the world's major health systems, leaving patients and drug companies to suffer. UK health spending, presently 9.9% of GDP, should rise to 11.3%, according to the ABPI's published election campaign requests. The demands come as GSK, the UK's biggest drugs company, announced a £2bn rise in first-quarter profits on revenues of £7.4bn.
The global pharmaceutical industry will abandon the UK unless the country's National Health Service (NHS) receives an extra £20bn ($26bn), warned a major industry trade group. The Association of the British Pharmaceutical Industry (ABPI) argued that the increased rationing of treatments is a sign that the NHS is falling in the ranks of the world's major health systems, leaving patients and drug companies to suffer. UK health spending, presently 9.9% of GDP, should rise to 11.3%, according to the ABPI's published election campaign requests. The demands come as GSK, the UK's biggest drugs company, announced a £2bn rise in first-quarter profits on revenues of £7.4bn.